Evidence map›Paper›PMID 27363578›Full record

Trial reportTrials2016

Efficacy and safety of using a warming needle for persistent allergic rhinitis: study protocol for a randomized controlled trial.

Yuxiu Sun, Hong Zhao, Yongming Ye, Wenbin Nie, Wenjing Bai, Jia Liu, Sinuo Li, Fang Wang, Mingjuan Han, Liyun He

Registry-linked trialOpen access · goldAbstract readComparative StudyEquivalence TrialMulticenter Study
In one paragraph

Trial report in Trials, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02339714 (Effect Comparison of Acupuncture Combined With Moxibustion and Loratadine for Perennial Allergic Rhinitis), which is not on this map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
0.4field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02339714 phase2completednot on this map

Effect Comparison of Acupuncture Combined With Moxibustion and Loratadine for Perennial Allergic Rhinitis: a Randomized Controlled Trial

TypeinterventionalSponsorZhao HongRan2015 to 2018Enrolled98ConditionsRhinitis, Allergic, PerennialArmsacupuncture combined moxibustion, Loratadine
3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yuxiu SunGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Hong ZhaoInstitute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, 100700, China. hongzhao2005@aliyun.com.
Yongming YeGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Wenbin NieMentougou Hospital of TCM, Beijing, 102300, China.
Wenjing BaiChina Academy of Chinese Medical Sciences, Beijing, 100700, China.
Jia LiuChina Academy of Chinese Medical Sciences, Beijing, 100700, China.
Sinuo LiGuang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing, 100053, China.
Fang WangInstitute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Mingjuan HanInstitute of Acupuncture and Moxibustion, China Academy of Chinese Medical Sciences, Beijing, 100700, China.
Liyun HeChina Academy of Chinese Medical Sciences, Beijing, 100700, China.
Chinese Academy of Medical Sciences & Peking Union Medical College · CNBeijing Chuiyangliu Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMany previous studies have shown the potential therapeutic effect of acupuncture for allergic rhinitis. Most of these studies, however, were limited by the short duration of observations and lack of sham acupuncture as the control group. Our preliminary experiments showed that the use of a warm needling achieved a much more persistent effect in the treatment of allergic rhinitis (AR) compared with simple acupuncture therapy. Hence, we have designed a multicenter, randomized controlled trial (RCT) in which the first-line medication loratadine will be used as the control group, and the effect of warm needling therapy will be evaluated through long-term observation. METHODS/

designThe trial is designed as a multicenter, parallel-group, randomized, single-blinded (outcome assessors), non-inferiority trial. A total of 98 patients with persistent AR will be randomly assigned into two groups. Patients in the treatment group will be treated with warm needling at GV14 and acupuncture at EX-HN3, ST2, LI20, EX-HN8, GV23, LU7, LU5 and LI4 three times a week, for a total of 4 weeks. Patients in the control group will be treated with oral loratadine 10 mg/day for 4 weeks. The primary outcome will be the change in the Total Nasal Symptom Score (TNSS) from baseline to that at 6 months after treatment during the follow-up period. The secondary outcomes will include the Total Non-nasal Symptom Score and the Rhinoconjunctivitis Quality of Life Questionnaire, changes in the TNSS from baseline to that at 2 and 4 weeks during treatment, and 3 months after treatment during the follow-up period. Outcomes will be measured at 2 and 4 weeks, and 3 and 6 months after treatment. Any side effects of treatment will be observed and recorded. DISCUSSION: We expect that the study results will provide evidence to determine the effects of warm needling compared with loratadine. Our final goal of the study is to evaluate the difference in the short-term and long-term effects between the two therapeutic methods, especially the long-term effect of warm needling.

trial registrationClinicalTrials.gov NCT02339714 . Registered on 14 January 2015.

Indexed as

NeedlesAcupuncture TherapyAdolescentAdultAnti-Allergic AgentsChinaClinical ProtocolsFemaleHot TemperatureHumansLoratadineMaleMiddle AgedQuality of LifeResearch DesignRhinitis, AllergicAnti-Allergic AgentsLoratadineAcupuncturePersistent allergic rhinitisRCTStudy protocolWarm needling

Identifiers

PMID27363578
PMCPMC4929718
OpenAlexW2469201244

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.